Reduction in sclerotic graft-versus-host-disease after post-transplant cyclophosphamide-based regimen comapared to traditional tacrolimus-based regimens in allogeneic hematopoietic cell transplant recipients: a retrospective cohort study
收藏Mendeley Data2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/n925sv5cr3/1
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary materials for "Reduction in sclerotic graft-versus-host-disease after post-transplant cyclophosphamide-based regimen comapared to traditional tacrolimus-based regimens in allogeneic hematopoietic cell transplant recipients: a retrospective cohort study"
《异基因造血细胞移植受者（allogeneic hematopoietic cell transplant recipients）中，移植后以环磷酰胺为基础的治疗方案（post-transplant cyclophosphamide-based regimen）相较于传统他克莫司治疗方案（traditional tacrolimus-based regimens）可降低硬化性移植物抗宿主病（sclerotic graft-versus-host-disease）发生率：一项回顾性队列研究（retrospective cohort study）》一文的补充材料
提供机构：
Harvard Medical School; Massachusetts General Hospital
